Effects of Individual and Group Education on Mothers' Attitudes and Decisions About Childhood Vaccination
Condition(s) studied
Investigational drug(s) / intervention(s)
Vaccination attitude: This study was planned to determine the effect of face-to-face and group education given to mothers regarding childhood vaccinations on their attitudes and decisions about vaccination. It is thought that the education provided will help eliminate mothers' misconceptions and false beliefs about vaccines in the short term and contribute to positive changes in their attitudes and decisions regarding vaccination. Moreover, it is anticipated that, in the long term, this intervention will contribute to achieving better immunization rates and protecting children from vaccine-preventable diseases. This study is also important in terms of emphasizing the midwife's role in protecting and improving infant and community health.
Study summary
This study was planned to determine the effect of face-to-face and group education given to mothers regarding childhood vaccinations on their vaccination attitudes and decisions. It is believed that the education provided will help eliminate mothers' misconceptions and false beliefs about vaccines in the short term, and contribute to positive changes in their attitudes and decisions regarding vaccination. Moreover, it is anticipated that in the long term, this intervention will contribute to achieving better immunization rates and protecting children from vaccine-preventable diseases. This study is also important in terms of emphasizing the role of midwives in protecting and improving infant and community health.This study will be carried out as a randomized controlled experimental study to determine the effect of face-to-face and group education given to mothers regarding childhood vaccinations on their attitudes and decisions about vaccination. Mothers who have children within the age range in which childhood vaccinations are administered will be contacted and informed about the purpose and scope of the study, and they will be asked whether they agree to participate. Mothers who consent to participate will be randomly assigned into three groups using computer-assisted randomization (https://www.random.org/
): Group 1: Mothers receiving individual face-to-face education, Group 2: Mothers receiving group education, and Group 3: Control group (receiving the routine unit-based information).
Eligibility
Primary outcome measure(s)
- Vaccine Opposition Scale — 6 month
The total score of the long form ranges from 21 to 105, while the total score of the short form ranges from 12 to 60. Higher scores on the scale indicate higher levels of vaccine hesitancy among participants."The long form of the scale demonstrated high internal consistency (Cronbach's alpha = 0.905)." - Vaccine Attitudes Scale — 6 month
Each item on the Vaccine Attitudes Scale is scored as agree = 1, undecided = 2, and disagree = 3. The total score is calculated by summing the item scores. The possible total score ranges from 11 to 33, where a score of 11 indicates a positive parental attitude toward vaccination, and a score of 33 indicates a negative attitude toward vaccination. The scale does not have a cut-off point. As the total score increases, parental vaccine hesitancy increases, reflecting a more negative attitude toward vaccination. "The Turkish version of the scale demonstrated acceptable internal consistency (Cronbach's alpha = 0.66)." - Data Collection Form — 6 month
This form was developed by the researcher and the advisor based on the relevant literature (Yorulmaz et al., 2024; Ünsal, 2020; Yiğit et al., 2020; Hazır, 2018) and consists of 27 questions. It will be used in the study to determine mothers' demographic and descriptive characteristics and their decisions regarding vaccination.
Trial sites (1)
| Facility | City | Region | Status |
|---|---|---|---|
| Rumeli Aile Sağlığı Merkezi | Istanbul | Bağcılar |
More Istanbul University - Cerrahpasa trials in Turkey
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07324356 on ClinicalTrials.gov ↗ ← All trials in Turkey